AGF Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,332
| Closed | -$258K | – | 701 |
|
|
2025
Q1 | $258K | Sell |
2,332
-2,301
| -50% | -$254K | ﹤0.01% | 639 |
|
|
2024
Q4 | $632K | Buy |
+4,633
| New | +$632K | ﹤0.01% | 603 |
|
|
2024
Q2 | – | Sell |
-16,637
| Closed | -$2.29M | – | 737 |
|
|
2024
Q1 | $2.29M | Sell |
16,637
-8,209
| -33% | -$1.13M | 0.01% | 448 |
|
|
2023
Q4 | $3.27M | Sell |
24,846
-3,669
| -13% | -$483K | 0.02% | 325 |
|
|
2023
Q3 | $3.21M | Sell |
28,515
-9,084
| -24% | -$1.02M | 0.02% | 313 |
|
|
2023
Q2 | $3.55M | Buy |
37,599
+3,197
| +9% | +$301K | 0.03% | 366 |
|
|
2023
Q1 | $3.48M | Buy |
34,402
+7,166
| +26% | +$725K | 0.02% | 336 |
|
|
2022
Q4 | $3.25M | Buy |
+27,236
| New | +$3.25M | 0.02% | 411 |
|